Envoy Medical Reports $66K Revenue, $0.50 EPS Loss for 3Q 2026
Revenue rose 57.1% year over year, while the net loss narrowed. Gains from remeasuring warrant liabilities and the absence of related-party interest expense more than offset higher operating costs.
Envoy Medical’s revenue rose 57.1% year over year, while its net loss narrowed as gains from remeasuring private and publicly traded warrant liabilities and the absence of related-party interest expense more than offset higher operating costs. Research and development spending increased with the ex…